WO2023017122A1 - System and method of the production and isolation of charged radionuclides - Google Patents
System and method of the production and isolation of charged radionuclides Download PDFInfo
- Publication number
- WO2023017122A1 WO2023017122A1 PCT/EP2022/072556 EP2022072556W WO2023017122A1 WO 2023017122 A1 WO2023017122 A1 WO 2023017122A1 EP 2022072556 W EP2022072556 W EP 2022072556W WO 2023017122 A1 WO2023017122 A1 WO 2023017122A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- liquid
- gas
- radionuclides
- electrode
- charged
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 34
- 238000002955 isolation Methods 0.000 title claims abstract description 11
- 238000004519 manufacturing process Methods 0.000 title description 17
- 239000007788 liquid Substances 0.000 claims abstract description 157
- 230000002285 radioactive effect Effects 0.000 claims abstract description 107
- 230000005684 electric field Effects 0.000 claims abstract description 40
- 239000007789 gas Substances 0.000 claims description 168
- 239000012159 carrier gas Substances 0.000 claims description 23
- 238000002360 preparation method Methods 0.000 claims description 3
- 239000000463 material Substances 0.000 description 41
- 239000000243 solution Substances 0.000 description 18
- 239000012530 fluid Substances 0.000 description 14
- 150000002500 ions Chemical class 0.000 description 13
- 229910052704 radon Inorganic materials 0.000 description 12
- SYUHGPGVQRZVTB-UHFFFAOYSA-N radon atom Chemical compound [Rn] SYUHGPGVQRZVTB-UHFFFAOYSA-N 0.000 description 12
- 230000000694 effects Effects 0.000 description 11
- 230000032258 transport Effects 0.000 description 11
- 239000002245 particle Substances 0.000 description 9
- 230000005258 radioactive decay Effects 0.000 description 9
- 239000007787 solid Substances 0.000 description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- 230000005855 radiation Effects 0.000 description 8
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 7
- 150000001875 compounds Chemical class 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 150000003839 salts Chemical class 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 239000003960 organic solvent Substances 0.000 description 6
- 238000002560 therapeutic procedure Methods 0.000 description 6
- ZSLUVFAKFWKJRC-IGMARMGPSA-N 232Th Chemical compound [232Th] ZSLUVFAKFWKJRC-IGMARMGPSA-N 0.000 description 5
- 229910052776 Thorium Inorganic materials 0.000 description 5
- 239000003929 acidic solution Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 230000002378 acidificating effect Effects 0.000 description 4
- 238000000151 deposition Methods 0.000 description 4
- 230000008021 deposition Effects 0.000 description 4
- 238000004090 dissolution Methods 0.000 description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 239000011707 mineral Substances 0.000 description 4
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Substances [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 4
- 229910052699 polonium Inorganic materials 0.000 description 4
- HZEBHPIOVYHPMT-UHFFFAOYSA-N polonium atom Chemical compound [Po] HZEBHPIOVYHPMT-UHFFFAOYSA-N 0.000 description 4
- -1 polyethylene Polymers 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000005587 bubbling Effects 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 238000010668 complexation reaction Methods 0.000 description 3
- 239000004020 conductor Substances 0.000 description 3
- 230000006866 deterioration Effects 0.000 description 3
- 238000010828 elution Methods 0.000 description 3
- 238000001730 gamma-ray spectroscopy Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 229910052697 platinum Inorganic materials 0.000 description 3
- 229910052705 radium Inorganic materials 0.000 description 3
- HCWPIIXVSYCSAN-UHFFFAOYSA-N radium atom Chemical compound [Ra] HCWPIIXVSYCSAN-UHFFFAOYSA-N 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 239000011343 solid material Substances 0.000 description 3
- 239000010935 stainless steel Substances 0.000 description 3
- 229910001220 stainless steel Inorganic materials 0.000 description 3
- 230000008685 targeting Effects 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- WEQHQGJDZLDFID-UHFFFAOYSA-J thorium(iv) chloride Chemical compound Cl[Th](Cl)(Cl)Cl WEQHQGJDZLDFID-UHFFFAOYSA-J 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229910052770 Uranium Inorganic materials 0.000 description 2
- 229910021536 Zeolite Inorganic materials 0.000 description 2
- 239000003570 air Substances 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 239000000956 alloy Substances 0.000 description 2
- 229910045601 alloy Inorganic materials 0.000 description 2
- 230000005262 alpha decay Effects 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 239000012062 aqueous buffer Substances 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000013375 chromatographic separation Methods 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 239000008139 complexing agent Substances 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 150000003983 crown ethers Chemical class 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 239000011888 foil Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000001307 helium Substances 0.000 description 2
- 229910052734 helium Inorganic materials 0.000 description 2
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- 239000002808 molecular sieve Substances 0.000 description 2
- 229910017604 nitric acid Inorganic materials 0.000 description 2
- 229910000510 noble metal Inorganic materials 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 239000003495 polar organic solvent Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000001959 radiotherapy Methods 0.000 description 2
- 238000009877 rendering Methods 0.000 description 2
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229910052721 tungsten Inorganic materials 0.000 description 2
- JFALSRSLKYAFGM-UHFFFAOYSA-N uranium(0) Chemical compound [U] JFALSRSLKYAFGM-UHFFFAOYSA-N 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- 239000010457 zeolite Substances 0.000 description 2
- 208000003788 Neoplasm Micrometastasis Diseases 0.000 description 1
- 206010033128 Ovarian cancer Diseases 0.000 description 1
- 206010061535 Ovarian neoplasm Diseases 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 208000007660 Residual Neoplasm Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 229910052768 actinide Inorganic materials 0.000 description 1
- 150000001255 actinides Chemical class 0.000 description 1
- OFHCOWSQAMBJIW-AVJTYSNKSA-N alfacalcidol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C OFHCOWSQAMBJIW-AVJTYSNKSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 238000010420 art technique Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- AGXUVMPSUKZYDT-UHFFFAOYSA-L barium(2+);octadecanoate Chemical compound [Ba+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O AGXUVMPSUKZYDT-UHFFFAOYSA-L 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000011889 copper foil Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 238000004070 electrodeposition Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001641 gel filtration chromatography Methods 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- OHSVLFRHMCKCQY-NJFSPNSNSA-N lutetium-177 Chemical compound [177Lu] OHSVLFRHMCKCQY-NJFSPNSNSA-N 0.000 description 1
- 230000009456 molecular mechanism Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 229910052756 noble gas Inorganic materials 0.000 description 1
- 230000009437 off-target effect Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 238000009520 phase I clinical trial Methods 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000000163 radioactive labelling Methods 0.000 description 1
- 239000012217 radiopharmaceutical Substances 0.000 description 1
- 229940121896 radiopharmaceutical Drugs 0.000 description 1
- 230000002799 radiopharmaceutical effect Effects 0.000 description 1
- 230000003439 radiotherapeutic effect Effects 0.000 description 1
- SYUHGPGVQRZVTB-YPZZEJLDSA-N radon-220 atom Chemical compound [220Rn] SYUHGPGVQRZVTB-YPZZEJLDSA-N 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000002626 targeted therapy Methods 0.000 description 1
- 231100001274 therapeutic index Toxicity 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 229960000575 trastuzumab Drugs 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
- G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
- G21G1/00—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
- G21G1/0005—Isotope delivery systems
Definitions
- the invention relates to a method and apparatus for the production of radionuclides formed by the decay of radioactive gas following by capturing of charged daughter radionuclides using an electric field.
- the present invention further relates to a method for the production of radionuclides for use in therapeutic applications.
- an alpha-emitting radionuclide is attached to a compound adhering to (receptors of) specific cancer cells, thereby delivering a (fatal) dose of alpharadiation to the cancer cells, leaving healthy cells largely unaffected.
- the perspective of this method is an effective treatment without major side effects, by a targeted therapeutic approach.
- Beta- emitters such as Lutetium 177 are already showing a large perspective for these type of targeted therapy applications, but alpha emitters hold the promise of higher therapeutic efficiency, either used as the single radiation damage providing radionuclide, or in combination with other beta- or Auger emitting radionuclides or other types of therapy.
- Different alpha-emitting radionuclides can be foreseen for being used for TAT, for example Ac-225, At-211 , Th-227, Ra-223 and more, depending on the targeting compound characteristics and requirements, such as chemical binding of the radionuclide to the compound, half-life, decay chain characteristics and alpha-damage profile.
- availability, affordability, ease-of-use and manufacturability determine which alpha-emitting radionuclide will be widely implemented in clinics.
- TAT in which the a-particle emitting radionuclide is specifically directed to a biological target, is gaining more attention to treat cancers as new targets are validated.
- Bio-vectors such as monoclonal antibodies are able to selectively transport alpha emitters to these cells.
- TAT has the potential for an improved therapeutic ratio over beta- emitter targeted conjugate therapy.
- the short path length and the intense ionization path generated by the alpha particles render alpha-emitters suitable for effective treatment of tumour tissue, including micrometastases or residual tumour after surgical debulking.
- Pb-212 is the longer-lived parent radionuclide of Bi- 212 and serves as an in vivo generator of Bi-212. Pb-212 has demonstrated significant utility in both in vitro and in vivo models.
- Pb-212 has specific characteristics, that can make it a very suitable radionuclide for some alpha-therapies.
- Pb-212 itself is a beta emitter with a half-life just over 10 hours, and has one alpha emitter in the decay chain. This can have benefit for therapies in which the targeting compound leaves the tumour location relative quickly.
- the long half-life of for example the currently quite popular radionuclide Ac-225 can cause insufficient or off-target alpha radiation damage.
- the single alpha in the Pb-212 decay chain also avoids off-target effects in absence of multiple alpha-emissions, which occur in the decay chain of other alphaemitting radionuclides, as alpha-emission generally leads to dissociation of the radionuclide from the targeting compound.
- These dissociated parent radionuclide’s daughters can be subsequently distributed in the patient, which can lead to off-target damage by subsequent alpha-emissions of the radionuclide daughters.
- Th-228 is an 1 .9 year half-life radionuclide that can for example be extracted from Th-232, or extracted from neutron irradiated Ra-226. Th-228 can be used as a generator continuously producing Ra-224, an radionuclide with an approximately 3.5 day half-life. Ra- 224 can then subsequently be used as a generator to produce Pb-212, locally, near the patient or a central production location in the vicinity of hospitals.
- EP2854870 describes a method wherein Pb-212 is formed by the decay of Ra-224 which is bound to a solid medium and is isolated by extraction of Pb-212 followed by multiple chromatographic separations.
- WO2017220767 describes the generation of Pb212 labelled proteins using gel-filtration chromatography.
- WO2017093069 describes a method to obtain Pb-212 from a solid medium via a series of washing and elution steps over chromatography columns.
- LIS2018/00847474 describes methodology for the generation of daughter radionuclides such as Pb-212 by radioactive decay of gaseous Rn- 220 by capturing the Rn-220 via cryogenic cooling on a column packed with a soluble salt, allowing the Rn-220 to decay into Pb-212. The dissolution of the salt then allowed capturing the desired Pb-212 radionuclide.
- Applied Radiation and Isotopes 2001 , 45, 1021-1025 had described a Pb-212 generator wherein Rn-220 is generated from Th-228 barium stearate.
- the decay products, Po-216 and Pb-212 are allowed to deposit on the walls of a polyethylene bottle and are subsequently washed off with an acidic solution.
- Hassfjel et al., Applied Radiation and Isotopes 2001, 55, 433-439 has described a process and apparatus for the generation of Pb- 212 wherein Th-228 was allowed to decay into Rn-220.
- the radon was bubbled through a solution of an organic solvent (hexane/methanol).
- the Pb-212 formed was collected in the organic solvent and on the glass surface of the bubbler and was washed off with an acidic solution. All these methods require that the desired radionuclide is to be collected from an electrode or a surface, leading to additional handling, potential Pb-212 losses and potential contamination by the electrode or the surface.
- the present inventors have found a generic solution for the generation, capture and isolation of charged radionuclides generated from a gaseous source.
- a radioactive gas By generating a radioactive gas and allowing it to decay into charged radionuclides and application of an electric field, the ions are be selectively attracted to one of the electrodes.
- the charged radionuclides By placing a liquid in the line of flight of the charged radionuclides towards the electrodes, the charged radionuclides are captured in the liquid.
- the resulting solution contains the charged radionuclides immediately, largely avoiding direct deposition of the charged radionuclides and subsequent embedding by decay and recoil on the electrode surface.
- the invention pertains to a method for the generation of radionuclides comprising the steps of a. providing a radioactive gas, b. allowing the radioactive gas to decay to form charged daughter radionuclides, c. providing a liquid in contact with the gas, d. subjecting the charged daughter radionuclides (16) to an electric field between two electrodes, thereby absorbing the charged daughter radionuclides (16) in the liquid, and e. isolating the liquid comprising the charged daughter radionuclides (16).
- the invention pertains to an apparatus for the preparation and isolation of radionuclides comprising an emanation vessel (1) and a collection vessel (3), wherein the emanation vessel (1) is connected to the collection vessel (3) or wherein the emanation vessel (1) and collection vessel (3) are comprised in a singular vessel, a. wherein the emanation vessel (1) comprises i. a radioactive gas emanating source material (2), ii. optionally a gas inlet (4), b. wherein the collection vessel (3) contains i. a first electrode (5) connected to an electric source (8), ii. a second electrode (6) connected to the electric source (8), iii. a liquid section (7), iv. optionally a gas outlet (11).
- Figure 1 is a schematic representation of an embodiment of the invention wherein the emanation vessel (1) and the collection vessel (3) are one body.
- Figure 3 is a schematic representation of an embodiment of the invention wherein the emanation vessel (1) and the collection vessel (3) are separate bodies connected via a connection (15), and the radioactive gas source is provided by a solid radioactive source (2).
- Figure 4 is a schematic representation of an embodiment of the invention wherein the emanation vessel (1) and the collection vessel (3) are separate bodies connected via a connection (15), and the radioactive gas source is provided by a solid or fluid radioactive source (2) and the gas flow is bubbled through the liquid (7A) to capture the charged daughter ions (16).
- FIG 5 is a schematic representation of an embodiment of a part of the invention wherein the electrode (6) is provided under the liquid section (7) and outside the collection vessel (3) (Fig 5A), in the liquid section (7) (Fig 5B) or in (or embedded in) the outside wall of the collection vessel (3) collecting the liquid (7A) (Fig 5C).
- One of the advantages of the present invention resides in the provision of a method and an apparatus (generator) for charged daughter radionuclides (16) without using chromatographic separation using column materials to obtain the desired products.
- the method leads to the provision of high purity daughter radionuclides (16).
- the method leads to the provision of the daughter radionuclides (16) directly (without any further steps) in a liquid (7A) that is suitable for further isolation of the daughter radionuclides (16) from the liquid (7A) or its direct use. This is beneficial from a waste and material loss point of view. Further benefit is that column deterioration is avoided which allows the generator to be used for prolonged periods of time. This is further enhanced by the using of parent radionuclides with longer half-lives.
- the electric capturing in a liquid (7A) of the present invention is capable of rendering a high purity product without risk of column material contamination.
- the charged radionuclides (16) can be retrieved from the radioactive gas from which they are formed by providing an electric field in the gas flow.
- the electric field has sufficient strength thereby forcing the charged daughter radionuclides (16) to deposit on the oppositely charged electrode of the electric field generator.
- the positive pole encloses the gas flow, repels the positively charged radionuclides and guides the positively charged radionuclides to the negative pole, avoiding deposition by positive-positive electric repulsion. By providing the negative pole in solution, the charged radionuclides are captured in solution and not on the electrode.
- the radioactive gas can be provided as a gas or can be generated by providing a gas generator such as a radioactive source material (2) that decays into a radioactive gas.
- a carrier gas may be used to generate a gas flow that provides sufficient flow for the charged daughter radionuclides (16) of the radioactive gas to be absorbed (captured) in the liquid (7A).
- the liquid (7A) wherein the charged daughter radionuclides (16) are captured is preferably provided in an amount that is enough to shield or immerse the electrode from direct contact with the gas containing the charged daughter radionuclides (16).
- the attracted charged daughter radionuclides (16) are captured in the liquid (7A), their kinetic energy is reduced and they have a lower chance of becoming attached to the electrode. Also subsequent radioactive decay of charged daughter radionuclides (16) in the liquid (7A) reduces the chance of radionuclides becoming attached to or embedded in the electrode.
- the source of the radioactive gas can be a thorium (Th), Uranium (U) and/or a radium (Ra) radionuclide or another radionuclide that has a daughter radionuclide in the decay chain that is in gaseous form.
- the source of the radioactive gas can be provided as a single (point) source element, but it is preferred in embodiments to provide the source as a solution, a powder, a foam, a foil, a sponge, a salt or on a carrier.
- the radioactive gas can be effectively removed from the emanation source by providing a gas flow that carries the radioactive gas.
- the radioactive gas is provided in a (carrier) gas flow.
- the Ra-224 or Th-228 source material is provided and the natural decay chain will allow the radioactive gas to be formed.
- the radioactive gas is radon, preferably radon- 220 (half-life 51 seconds).
- the Rn-220 (Radon) decays into Po-216 (Polonium) and Pb-212 (Lead) charged radionuclides.
- the decay takes place in gas flow created by the radon and an optional carrier gas, and leads to loss of electrons, thereby generating positively charged Polonium and Lead ions.
- the half-life of Po-216 is 0.15 seconds.
- the Po-216 charged radionuclide will move towards the electrode provided in the liquid, possibly in microseconds.
- the Po-216 charged radionuclide will decay into Pb-212.
- This decay to Pb-212 is predominantly in the liquid (7A).
- the Pb-212 formed may move towards the electrode but is less prone to become embedded in the electrode since the recoil effect of the decay is predominantly in the liquid (7A) and not or to a lesser extent on the surface of the electrode, especially when compared to prior art techniques discussed herein above.
- the source material that can emanate the radioactive gas can be Ra-226.
- the characteristics of the processing equipment e.g. flow rate, filters and collection volume
- the Pb-212 will be mainly be captured in the collection volume while the Pb-impurities (e.g. Pb-214) will not decay in the collection volume. This allows obtaining high purity Pb-212.
- the method comprises maintaining the radioactive gas in absence of an electric field, preferably for a period of between 30 and 180 seconds prior to subjecting the gas to the electric field.
- the apparatus hence contains a chamber positioned between the emanation vessel (1) and the collection vessel (2), optionally via tubing, and wherein preferably the chamber is not provided with or influenced by the electric field in the collection vessel (3).
- the source of the radioactive gas such as the Th-228 or Ra-224 source
- the radioactive gas such as Rn, more preferably Rn-220
- Bubble formation can be promoted by providing a carrier gas with a carrier gas flow.
- the carrier gas will transport the radioactive gas from the emanating source.
- the radioactive gas can adhere to the bubble surfaces and/or enters the bubbles, can be released from the liquid and transported from the liquid by the gas flow.
- the smaller the bubbles and the larger the amount of bubbles the more radioactive gas can be extracted from the fluid.
- the radioactive gas that is generated is effectively removed. It is preferred that bubble surface is maximized to allow the radioactive gas to be taken with or within the bubbles from the fluid. This can be achieved in multiple ways, but in case the gas flow needs to minimized, maximizing the amount of bubbles (minimizing bubble size) is preferred.
- the bubbling principle has been described in LIS2018/0047474. Minimizing the carrier gas flow is preferred to limit the required volume for the collection vessel (3).
- the gaseous daughter can be removed by flowing a carrier gas along a surface upon which the source material (2) of the radioactive gas, such as Th-228 and/or Ra-224 has been provided.
- the gaseous daughter in the case of Th-228 and/or Ra-224 this is Rn-220) is released by diffusion and/or recoil, and taken (further) from the source surface by the gas flow.
- the fluid in which the source of the radioactive gas is provided can be an aqueous fluid, a charged (ionic) fluid, an organic solvent or a mixture thereof.
- the organic solvent can be a polar organic solvent, such as DMF, DMSO, lower (C1-C4) alcohols.
- the source of the radioactive gas can be provide as a solution, dispersion or emulsion in the fluid.
- the aqueous fluid is one or more selected from the group consisting of water, an aqueous buffer and an aqueous acidic solution. There is a preference for an aqueous fluid in wherein the source of the radioactive gas is dissolved, such as a solution of a Th-228 salt.
- the acid in the acidic aqueous solution is selected from the group consisting of a mineral and an organic acid, preferably selected from the group consisting of hydrochloric acid, nitric acid, phosphoric acid, sulfuric acid, acetic acid, citric acid and mixtures thereof.
- a mineral acid more preferably hydrochloric acid.
- the fluid preferably has an acidic pH, such as a pH of ⁇ 7, preferably ⁇ 6, more preferably below 4.
- Alternative complexing agents and ligands can be used that are suitable for the complexation of dissolved ions of the source of the radioactive gas, like Th-228 or Ra-224 ions, such as EDTA and other nitrogen containing macrocycles or crown ethers.
- the thorium radionuclide can be Th-232, Th-230, Th-228, Th-227, preferably Th-228.
- the thorium radionuclide may also be provide as the uranium parent, U-232.
- the radium radionuclide can be Ra-226, Ra-224, Ra-223, preferably Ra-224.
- the radon radionuclide can be Rn-222, Rn-220, Rn-219, preferably Rn-220.
- the fluid or solid source in the emanation section which contains the U-232/Th-228/Ra-224 radioactive gas source can be exposed to a carrier gas flow (the gas flow allows removing gaseous daughters from the source from which radon emanates) thereby extracting gaseous Rn-220 from the source.
- the gaseous Rn-220 after decay the polonium and lead charged daughter radionuclides (16) are repelled by the positive electrode and attracted to the negative pole of the electric field.
- the polonium and lead ions are captured in solution directly and not on the electrode surface.
- the lead can be retrieved by removing the liquid in which the negative pole is immersed directly.
- the amount of dissolution liquid is not critical, as long as the whole negative pole is at least covered by the liquid.
- the radionuclide concentration can be tailored to need by using more or less liquid.
- the method of the present invention has at least similar efficiency in Pb-212 retrieval as a column set up, but avoids the use of columns, thereby limiting waste streams, elution losses and avoiding column deterioration by radiation damage.
- the liquid (7A) that is used for the capture of the daughter radionuclides (16) is preferably a liquid (7A) that is capable of capturing the daughter radionuclides (16) without decomposition of the liquid (7A) as a consequence of the radioactive decay of the radionuclides produced.
- the liquid (7A) can be a liquid that allows for the easy and convenient further handing of the daughter radionuclides (16).
- the liquid (7A) is an aqueous liquid, a charged (ionic) liquid, an organic solvent or a mixture thereof.
- the organic solvent can be a polar organic solvent, such as DMF, DMSO, lower (C1-C4) alcohols.
- the aqueous liquid is one or more selected from the group consisting of water, an aqueous buffer and an aqueous acidic solution.
- TAT target alpha therapy
- the presence in the liquid of salts may aid in the function of the liquid as an electrically conductive solution, attracting the charged radionuclides and capable of capturing the charged daughter radionuclides, the use of a physiologically acceptable salt solution allows the direct further processing the captured charged daughter radionuclide.
- the acid in the acidic aqueous solution is selected from the group consisting of a mineral and an organic acid, preferably selected from the group consisting of hydrochloric acid, nitric acid, phosphoric acid, sulfuric acid, acetic acid, citric acid and mixtures thereof.
- a mineral acid more preferably hydrochloric acid.
- the liquid (7A) preferably has and acidic pH, such as a pH of ⁇ 7, preferably ⁇ 6, more preferably below 4.
- acidic pH such as a pH of ⁇ 7, preferably ⁇ 6, more preferably below 4.
- Alternative complexing agents and ligands can be used that are suitable for the complexation of charged radionuclides such as EDTA and other nitrogen containing macrocycles or crown ethers.
- the emanated radioactive gas from the source material (2) can be transported using a carrier gas.
- a carrier gas is advantageous as it transport the emanated gas away from the source.
- alpha decay as in the case of the Th-228/Ra-228/Rn-220/Po- 216/Pb-212 pathway has as one of its characteristics the presence of a recoil effect.
- the recoil effect can cause that the formed radionuclides when become embedded in surrounding solid material from which they are difficult to remove.
- the carrier gas aids in transporting the formed radioactive gas away from the source.
- the carrier gas is preferably an inert gas and/or a noble gas or a gas that is not affected by radioactive decay of the radionuclides present.
- the gas may also be air, oxygen or, carbon dioxide, as long it remains unaffected by radioactive decay.
- the carrier gas can be selected from the group consisting of nitrogen, helium, argon, carbon dioxide, air and mixtures thereof. There is a preference for nitrogen and/or helium or mixtures thereof.
- the flow of the carrier may vary and can be determined depending on the circumstances.
- the flow is preferably high enough to transport the radioactive gas away from the source material (2).
- the flow of the radioactive gas and optional carrier gas should be enough to avoid loss by decay, by neutralization or by embedding in solid materials by decay and recoil underway.
- the gas flow should be adequate to transport the radioactive gas that is formed and liberated from the source material (2) over a distance such that any radioactive decay involving alpha particles does not leave the daughter radionuclides (16) embedded in the source material due to a recoil effect.
- the flow should be high enough to bring the radioactive gas and the charged daughter radionuclides (16) formed within the reach of the electric field such that any charged daughter radionuclides (16) are attracted towards the liquid (7A) embedded electrode .
- the gas flow should be preferably chosen in a ratio to the total system volume per minute of 1:1 to 1 :25. For example, if the total system volume is 250 mL, the gas flow should be preferably chosen in the range of 10-250 mL/min.
- Rn-220 is emanated as a radioactive gas and can be removed from the surface of the source material (2) by the gas flow.
- the Rn-220 emits an alpha particle, resulting in Po-216 ion as a charged radioactive daughter radionuclide with a very short half-life.
- the Po-216 emits also an alpha particle, resulting in Pb-212 as a charged radioactive daughter radionuclide.
- Both charged radioactive daughter radionuclide Po-216 and Pb- 212 can be influenced by the applied electric field between the electrodes (5,6).
- the electric field is provided between two electrodes (5,6) (a positive electrode and a negative electrode). Each electrode can contain one or more multiple electrodes.
- the electric field is maintained between the electrodes (5,6) by isolating the two electrodes (5,6) from each other such that no current flows.
- the electric field is maintained to capture any charged daughter radionuclides (16).
- the charged daughter radionuclides (16) are subject to an electric field between the two electrodes (5,6).
- the electric field between the electrodes (5,6) will attract the charged daughter radionuclides (16) to the electrode that has the opposite charge of the charged daughter radionuclide.
- the charged daughter radionuclides (16) will be repelled by the electrode that carries the opposite charge.
- the efficiency of attracting the charged daughter radionuclides (16) to the electrode will depend, among others, on the strength of the electric field.
- the electric field strength between the electrodes (5,6) is such that the charged daughter radionuclides (16) are attracted to the electrode.
- the strength of the electric field also depends on the medium, the dielectric.
- the voltages over the electrodes (5,6) is typically between 10 and 10.000 volt, between 100 and 7500 volt, between 500 and 5000 volt. This provides an adequate electric field.
- the gas is contacted with a liquid, wherein the liquid (7A) carries an electric charge, preferably a negative charge.
- the negative charge can be provided to the liquid (7A) by providing an electric field.
- the oppositely charged daughter radionuclides (16) are attracted to the liquid (7A) and captured therein.
- the liquid (7A) is negative charged.
- the method of the invention can be performed at a reduced pressure (from 0.01 up to 1 bar), ambient pressure (about 1 bar) or increased pressure (more than 1 bar).
- the method of the invention can be performed at a temperature between 5 and 100 degrees Celsius, more preferably between 10 and 90 degrees Celsius. It is considered advantageous to use a temperature above ambient in the gas emanating source to remove the radioactive gas from the gas emanating source.
- the electric field between the electrodes (5,6) causes the charged radioactive daughter radionuclides (16) to be absorbed in the liquid.
- This provides a solution of the charged radioactive daughter radionuclides (16) in the liquid (7A).
- the liquid (7A) is placed between the (electric field of the) electrodes (5,6).
- the electric field will attract the charged radioactive daughter radionuclides (16) towards one of the electrodes (5,6) and repel them from the other electrode (5,6).
- the suitable selection of the charge of the electrode (positive or negative) and the positioning of the liquid (7A) between the electrodes (5,6) cause the charged radioactive daughter radionuclides (16) to be captured in the liquid (7A) (positive ions to the negative electrode and negative ions to the positive electrode).
- the charged daughter radionuclides (16) that are attracted to the electrode are captured in the liquid (7A).
- This capturing step of the process provides the radioactive daughter ions directly in the liquid (7A) and limits or prevents the radionuclides being deposited directly on the electrode surface.
- the liquid (7A) can be isolated, used as is, or subject to furthers steps such as purification, complexation and use as a radiochemical material for further labelling or synthesis of radiopharmaceutical end products for in targeted radiotherapy.
- the invention pertains to a method for the generation of Pb-212 radionuclides comprising the steps of a. providing a Rn-220 gas, b. allowing the radioactive gas to decay to form charged daughter radionuclides (16) comprising Po-216 and/or Pb-212 , c. providing a liquid (7A) in contact with the radioactive gas, d. subjecting the charged daughter radionuclides (16) to an electric field between two electrodes (5,6) thereby absorbing the Po-216 and/or Pb-212 charged daughter radionuclides (16) in the liquid, and e. isolating the liquid (7A) comprising the charged daughter radionuclides.
- the Rn-220 gas decays into Po-216 as the charged daughter radionuclide by the emission of an alpha particle.
- the Po-216 will, due to electric field move towards the oppositely charged electrode in a matter of milliseconds.
- the Po-216 will subsequently decay in to Pb-212, preferable and predominantly in the liquid (7A).
- the radioactive gas emanating source (2) can be a radon emanating source.
- the apparatus (the generator of charged radionuclides) of the invention can be manufactured out of radiation resistant and inert materials, that can withstand the conditions in the generator for a long time, and can therefore accommodate the parent radionuclides such as U-232/Th-228/Ra-224.
- the emanation vessel (1) comprising the radioactive gas emanating source material (2) can be provided in the form of a container capable of containing a fluid comprising the radioactive gas emanating source (2) or in a form that allows the radioactive gas emanating source (2) to be provided as a single (point) source element, but it is preferred in embodiments to provide the source as a solution, a powder, a foam, a foil, a sponge, a salt or on a carrier.
- the source material (2) may be provided in elemental form or as a compound, such as a salt or oxide.
- the emanation vessel (1) may further be provided with a gas inlet (4).
- the gas inlet (4) can be used for the provision of a carrier gas to transport the emanated radioactive gas.
- the emanation vessel (1) can be removably connected to the collection vessel (3) to allow exchange of radioactive gas emanating source material (2), for instance when the source material (2) is depleted.
- a separate gas supply may be provided, connected to the gas inlet
- the emanation vessel (1) can be removably connected to the collection vessel (3).
- the emanation vessel (1) can be in direct contact with the collection vessel (3) or via a connecting element (15) such as a connection tube.
- the emanation vessel (1) is connected to the collection vessel (3) at one end of the collection vessel (3).
- the connecting element (15) may also function as a gas outlet of the emanation vessel (1) to transport the gas from the emanation vessel (1) to the collection vessel (3).
- the emanation vessel (1) and the collection vessel (3) together form a closed vessel. Gas and liquids can be provided to the closed vessel and removed from the closed vessel through provided inlets and outlets for liquid and/or gas.
- the collection vessel (3) is provided with two electrodes (5) and (6) connected to a power source/voltage generator (8).
- the collection vessel (3) has a volume (holding section).
- the volume of the holding section is selected such that the radioactive gas (optionally in combination with the flow generated by a carrier gas) remains in this volume for a period sufficient to allows the radioactive gas to predominately (more than 90%) decay in to charged daughter radionuclides.
- the holding section is capable of collecting the radioactive gas for a time sufficient to yield charged daughter radionuclides. For instance in the case of radion-220, with a half time of 51 seconds, the preference collection time is about 5 minutes.
- the preferred collection time is from one to ten, preferably from about three to seven times the halftime of the radioactive gas.
- the preferred collection time is a compromise between:
- Electrode (6) is provided in a liquid (7A) or is located under the liquid (7A).
- the liquid (7A) is preferably located at the bottom end of the collection vessel (3) .
- the section of the collection vessel (3) that contains the liquid (7A) can be depicted as the liquid section (7).
- the liquid section (7) contains the liquid (7A) .
- the liquid (7A) is at least partially within the electric field between the two electrodes (5,6).
- the electrode (6) is preferably immersed in the liquid (7A) or is located in a separate section below the liquid, such as encompassed or incorporated in the bottom of the vessel in such a way that the electric field between the electrodes (5,6) passes through the liquid (7A) and is capable of exerting an electric force on the charged radioactive daughter radionuclides.
- a gas outlet (11) is connected to the collection vessel (3) .
- the gas outlet (11) is located near the surface of the liquid (7A) in the collection vessel (3) such that the gas flow from the emanation source flows through the collection vessel (3) to the gas outlet (11).
- the carrier gas can transport the radioactive gas form the emanation vessel (1) through the collection vessel (3). Through natural radioactive decay, the radioactive gas will form radioactive charged daughter radionuclides.
- the charged daughter radionuclides in the preferred case of Rn-220, charged daughter radionuclides (16) Po-216 and Pb-212 are formed, are repelled by electrode (5) encompassing the gas volume and are attracted by the negative electrode (6) and will be absorbed by the liquid (7A).
- the radioactive charged daughter radionuclides (16) formed can be isolated by removal from the liquid section (7). Removal and /or exchange from the liquid section (7) can be achieved by providing the liquid section (7) with a liquid inlet (9) and/or a liquid outlet (10).
- the gas flow can exit the collection vessel (3) through the gas outlet (11).
- the gas outlet (11) can be placed above the surface of liquid, although in embodiments, the exiting gas can be transported or bubbled through the liquid (7A).
- the exited gas may be filtered from undesired particles and compounds through filter (13) and emitted through gas vent (14).
- the gas may be recirculated by providing a connection between the gas outlet (11) and the gas inlet (4).
- the removed fluid contains the liquid comprising the radioactive daughter ions.
- the radioactive gas emanating source can be a thorium or radium radionuclide.
- the emanation vessel (1) can be removably connected to the collection vessel (3) to allow exchange of radioactive gas emanating source material (2), for instance when the source material (2) is depleted.
- the emanation vessel (1) contains an insertable module containing the radioactive source material (2) to allow exchange of the source material (2).
- the collection vessel (3) preferably the liquid section (7) comprises a liquid outlet and/or liquid inlet.
- a liquid (7A) in and/or outlet allows for the exchange and/ or removal of the liquid (7A) contain the formed charged daughter radionuclides (16) without disassembly of the apparatus.
- the electrode (6) is placed outside the liquid section (7) of the collection vessel (3) .
- the electrode placed outside the collection vessel (3) can for instance be placed directly underneath the liquid section (7) or incorporated/embedded in the material of the liquid section (7).
- the material of the liquid section (7) is preferable a solid material having a relative low electric permittivity, allowing the electric field to exert an attracting force on charged daughter radionuclides. Examples are plastics, glass or composites.
- the electrode (6) is placed in the liquid (7A) in the liquid section (7).
- the electrode (6) is positioned in the liquid section (7) such that the electrode (6) is immersed in the liquid (7A). It is preferred that in certain embodiments, the electrode (6) is separated from the electrode (5) by the liquid (7A). Preferably, the electrode (6) is isolated from/ is not in electrical contact with electrode (5), using electric isolation (12) .
- the collection vessel (3) comprises a holding section connected to the liquid section (7).
- the holding section (18) serves to hold the gas for a period long enough for the charged daughter radionuclides (16) to form through decay of the radioactive gas.
- the holding section (18) is placed between the emanation section (or the connection tube) and the liquid section (7).
- the holding section (18) connected to the liquid section (7) may be electrically isolated from the liquid section (7).
- the two electrodes (5, 6) are preferably connected to allow a voltage to be applied over the electrode.
- the voltage can be provided by a voltage generator (8) in contact with the electrodes (5,6).
- the holding section (18) or the liquid section (7) contains a gas outlet (11).
- the electrode (5) is a conductive material significantly encompassing the holding section (18).
- the holding section (18) is a conductive material.
- the electrode (6) is an electrical conductive material such as a noble metal, Pt, W, stainless steel, alloys, carbon, copper, aluminum.
- the choice of materials is preferably inert to the liquid (such as an acidic solution) like noble metals, Pt, W, stainless steel, alloys, carbon etc.
- the gas outlet (11) contains a filter such as a carbon or HEPA filter.
- the emanation vessel (1) and collection vessel (3) can be combined in one body, for instance with the radioactive source on top through which a carrier gas can carry the radioactive gas to the collection vessel (3) .
- the wall of the collection vessel (3) and in particular the holding section (18), is connected to the power source and functions as the electrode (5), and set at an electrical charge to preventing deposition of the formed charged daughters.
- the liquid (7A) is provided in the liquid section (7) at a position where the electrode (6) (charged opposite to the charged daughter radionucleotides), that is connected to the power source, is immersed in the liquid (7A) and/or wherein the liquid (7A) encompasses the electrode or is placed between the electrodes (5,6) in such a way that the electric field generated between the electrodes (5,6) forces the charged daughters radionuclides to move and be absorbed by the liquid (7A).
- the charged daughters radionuclides in the case of the Rn-220 to Pb-212 decay chain positively charged
- the (in the case of the Rn- 220 to Pb-212 negatively charged) electrode are attracted to the (in the case of the Rn- 220 to Pb-212 negatively charged) electrode and are subsequently captured and absorbed in the liquid (7A) in the liquid section (7).
- the emanation vessel (1) and collection vessel (3) can be two separate bodies, connected though a connection tube (15).
- the emanation vessel (1) contains a liquid comprising the radioactive source, such as Th-228 and/or Ra-224.
- the radioactive source can be provided as a solution which avoids recoil of the daughter radionuclide in solid source material.
- the emanated gas can bubble out of the liquid, optionally aided by bubbling a carrier gas via a gas inlet (4) through the liquid containing the radioactive source material (2) such that the radioactive gas is carried along to the collection vessel (3) .
- the emanated gas can move away from the source material (2) via diffusion, optionally aided by providing a carrier gas via a gas inlet (4) along the solid containing the radioactive source material (2) such that the radioactive gas is carried along to the collection vessel (3) .
- the liquid section (7) can be configured as having two (tubular) legs connected by a (tubular) bend, for instance in a ll-type construction.
- the two connected legs contain a liquid (7A) .
- the equilibrium level of the liquid (7A) when there is no gas flow can be above the bend.
- the liquid surface in one leg is in contact with the gas in the collection vessel (3) .
- a connection tube or gas-pass-through (17) can be provided to allow the excess gas to transfer to the other leg.
- the excess gas can bubble through the liquid (7A) and improve the removal of any ions from the gas prior to exit through the gas vent (14).
- the positioning of electrode (6) is illustrated as below and outside the liquid section (7) (Fig 5A), inside the liquid section (7) (Fig 5B), and embedded in the material of the liquid section (7) (Fig 5C),
- the radioactivity amounts of the various radionuclides is measured using an high purity germanium detector.
- the experimental setup consists of an gas flow controller connected to a 25 mL emanation vial.
- the emanation vial is connected to a 400 mL collection vessel, which contains a gas inlet, gas outlet, liquid inlet/outlet, and a platinum electrode connected to the negative pole of the high voltage power supply (0 - 5 kV).
- a layer of copper foil is attached to the inside walls of the collection vessel, which is connected to the positive pole of the power supply.
- the gas outlet of the collection vessel is connected to a trapping column filled with zeolite molecular sieves.
- the amount of Th-228 in the Th-228 source is measured by gamma-spectroscopy measurement of the formed Pb-212, either after full ingrowth of the Pb-212, or by measuring in intervals and determining the ingrowth over time.
- the production capability of Pb-212 generated from the Th-228 source in the emanation vessel is determined by leading the carrier gas containing the Rn-220 through multiple trapping columns (zeolite). This column is of a size, which in combination with the gas flow, will trap any radon species and daughters in the gas stream, additional columns are added in series to confirm all Radon ad Radon-daughters are trapped and to ensure no Radon escapes to the environment. The trapped Rn-220 decays to Pb-212 on the trapping column.
- trapping columns zeolite
- Measuring the activity of Pb-212 on the trapping column by gamma-spectroscopy provides a (relative) quantification of the amount of Rn-2201 Pb-212 that is retrieved from the Th-228 source in the emanation vessel. This exercise is regularly repeated to ensure the Radon released from the source is stable and unchanged over the course of experiments.
- a solution of [Th-228]ThCl4 (5 mL, 50 MBq) is added to the emanation vial.
- the collection liquid is subsequently added to the collection vessel, with a volume large enough to fully submerge the negative electrode.
- a voltage of 3.5 kV is applied between the two electrodes, and a nitrogen flow of 50 mL/min is bubbled through the [Th-228]ThCl4 solution and led through the collection chamber towards column for different durations ranging from a few hours up to 24 hours. Subsequently, the gas flow and power supply is turned off, and the collection liquid is collected from the collection vessel.
- the trapping efficiency is determined by measuring the amount of Pb-212 collected in the collection liquid and comparing this to the previously determined production capability of the Th-228 source.
- the amount of Pb-212 collected on the trapping column filled with molecular sieves is measured to determine the amount of Pb-212 which emanated from the Th-228 source, but has not been collected in the collection liquid. The total amount measured is added up to what is expected to emanate from the source.
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA3228614A CA3228614A1 (en) | 2021-08-11 | 2022-08-11 | System and method of the production and isolation of charged radionuclides |
AU2022326825A AU2022326825A1 (en) | 2021-08-11 | 2022-08-11 | System and method of the production and isolation of charged radionuclides |
CN202280060101.0A CN117916822A (en) | 2021-08-11 | 2022-08-11 | System and method for producing and separating charged radionuclides |
IL310474A IL310474A (en) | 2021-08-11 | 2022-08-11 | System and method of the production and isolation of charged radionuclides |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP21190882 | 2021-08-11 | ||
EP21190882.7 | 2021-08-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2023017122A1 true WO2023017122A1 (en) | 2023-02-16 |
Family
ID=77595282
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2022/072556 WO2023017122A1 (en) | 2021-08-11 | 2022-08-11 | System and method of the production and isolation of charged radionuclides |
Country Status (5)
Country | Link |
---|---|
CN (1) | CN117916822A (en) |
AU (1) | AU2022326825A1 (en) |
CA (1) | CA3228614A1 (en) |
IL (1) | IL310474A (en) |
WO (1) | WO2023017122A1 (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5038046A (en) | 1990-07-10 | 1991-08-06 | Biotechnetics | Method and generator for producing radioactive lead-212 |
EP2854870A1 (en) | 2012-05-24 | 2015-04-08 | Areva Med SAS | Method and apparatus for the production of lead 212 for medical use |
WO2017093069A1 (en) | 2015-11-30 | 2017-06-08 | Areva Med Sas | New method and apparatus for the production of high purity radionuclides |
WO2017220767A1 (en) | 2016-06-24 | 2017-12-28 | Sciencons AS | Preparation of 212pb labeled monoclonal antibodies |
US20180047474A1 (en) | 2016-08-11 | 2018-02-15 | Battelle Memorial Institute | System, emanation generator, and process for production of high-purity therapeutic radioisotopes |
RU2742138C1 (en) * | 2020-05-20 | 2021-02-02 | Федеральное государственное унитарное предприятие "Производственное объединение "Маяк" | Method of obtaining 211pb/211bi for nuclear medicine |
-
2022
- 2022-08-11 WO PCT/EP2022/072556 patent/WO2023017122A1/en active Application Filing
- 2022-08-11 IL IL310474A patent/IL310474A/en unknown
- 2022-08-11 CN CN202280060101.0A patent/CN117916822A/en active Pending
- 2022-08-11 CA CA3228614A patent/CA3228614A1/en active Pending
- 2022-08-11 AU AU2022326825A patent/AU2022326825A1/en active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5038046A (en) | 1990-07-10 | 1991-08-06 | Biotechnetics | Method and generator for producing radioactive lead-212 |
EP2854870A1 (en) | 2012-05-24 | 2015-04-08 | Areva Med SAS | Method and apparatus for the production of lead 212 for medical use |
WO2017093069A1 (en) | 2015-11-30 | 2017-06-08 | Areva Med Sas | New method and apparatus for the production of high purity radionuclides |
WO2017220767A1 (en) | 2016-06-24 | 2017-12-28 | Sciencons AS | Preparation of 212pb labeled monoclonal antibodies |
EP3474904A1 (en) | 2016-06-24 | 2019-05-01 | Sciencons AS | Preparation of 212pb labeled monoclonal antibodies |
US20180047474A1 (en) | 2016-08-11 | 2018-02-15 | Battelle Memorial Institute | System, emanation generator, and process for production of high-purity therapeutic radioisotopes |
RU2742138C1 (en) * | 2020-05-20 | 2021-02-02 | Федеральное государственное унитарное предприятие "Производственное объединение "Маяк" | Method of obtaining 211pb/211bi for nuclear medicine |
Non-Patent Citations (7)
Title |
---|
BARANYAI A ET AL: "212Bi-212Po alpha source for the calibration and functional testing of silicon detectors: Preparation and characterisation", APPLIED RADIATION AND ISOTOPES, ELSEVIER, OXFORD, GB, vol. 158, 11 January 2020 (2020-01-11), XP086080311, ISSN: 0969-8043, [retrieved on 20200111], DOI: 10.1016/J.APRADISO.2019.109028 * |
EISWIRTH ET AL., J. OF CHEM. EDUCATION, vol. 59, 1982, pages 608 |
HASSFJELL ET AL., APPLIED RADIATION AND ISOTOPES, vol. 55, 2001, pages 1021 - 1025 |
J. NUCL. SCI. TECH., 1976, pages 270 |
SHINAGAWA ET AL., J. NUCL. SCI. TECH., 1968, pages 408 |
SHINAGAWA, J, NUCL. SCI. TECH., 1977, pages 163 |
TAKEMI ET AL., J. NUCL. SCI. TECH., 1973, pages 155 |
Also Published As
Publication number | Publication date |
---|---|
CN117916822A (en) | 2024-04-19 |
AU2022326825A1 (en) | 2024-02-15 |
CA3228614A1 (en) | 2023-02-16 |
IL310474A (en) | 2024-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Chakravarty et al. | Development of an electrochemical 90Sr–90Y generator for separation of 90Y suitable for targeted therapy | |
Chakravarty et al. | An electro-amalgamation approach to isolate no-carrier-added 177Lu from neutron irradiated Yb for biomedical applications | |
Apostolidis et al. | Cyclotron production of Ac-225 for targeted alpha therapy | |
RU2432632C2 (en) | METHOD OF EXTRACTING PURE 225Ac OBTAINED FROM IRRADIATED 226Ra TARGETS | |
EP0990238B1 (en) | Neutron-driven element transmutation | |
Schwarzbach et al. | Development of a simple and selective separation of 67Cu from irradiated zinc for use in antibody labelling: a comparison of methods | |
Lebedev et al. | Radiochemical separation of no-carrier-added 177Lu as produced via the 176Ybn, γ177Yb→ 177Lu process | |
WO1997007122A2 (en) | PRODUCTION OF 64Cu AND OTHER RADIONUCLIDES USING A CHARGED-PARTICLE ACCELERATOR | |
RU2630475C2 (en) | Radionuclide generator having first and second atoms of the first element | |
Schwarz et al. | Preparation of 211At-labeled humanized anti-Tac using 211At produced in disposable internal and external bismuth targets | |
Chakravarty et al. | Reactor production and electrochemical purification of 169Er: a potential step forward for its utilization in in vivo therapeutic applications | |
WO2023017122A1 (en) | System and method of the production and isolation of charged radionuclides | |
CA2938158C (en) | Method for producing beta emitting radiopharmaceuticals, and beta emitting radiopharmaceuticals thus obtained | |
Watanabe et al. | Production of no-carrier-added 64 Cu and applications to molecular imaging by PET and PETIS as a biomedical tracer | |
Mirzadeh et al. | Spontaneous electrochemical separation of carrier-free copper-64 and copper-67 from zinc targets | |
Hilgers et al. | Production of the therapeutic radionuclides 193mPt and 195mPt with high specific activity via α-particle-induced reactions on 192Os | |
Joshi et al. | Production of 125I from neutron irradiation of natural Xe gas and a wet distillation process for radiopharmaceutical applications | |
Nye et al. | Production of [124I]-iodine on an 11 MeV cyclotron | |
Chakravarty et al. | An electro-amalgamation approach to produce 175Yb suitable for radiopharmaceutical applications | |
Kostelnik et al. | Production and radiochemistry of antimony-120m: Efforts toward Auger electron therapy with 119Sb | |
KR20220098839A (en) | Method and system for producing medical radioisotopes | |
Koch et al. | Production of Ac-225 and application of the Bi-213 daughter in cancer therapy | |
Ismail | Alpha Particles Deposition and Its Effects on Lings, Male Infertility and Blood Components | |
Ruddy et al. | Separation of the alpha-emitting radioisotopes actinium-225 and bismuth-213 from thorium-229 using alpha recoil methods | |
Borković et al. | Comparison of sampling and measurement methods for atmospheric 14C activity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22765068 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 310474 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: 807859 Country of ref document: NZ Ref document number: AU2022326825 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 3228614 Country of ref document: CA |
|
ENP | Entry into the national phase |
Ref document number: 2022326825 Country of ref document: AU Date of ref document: 20220811 Kind code of ref document: A |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112024002724 Country of ref document: BR |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2022765068 Country of ref document: EP Effective date: 20240311 |